FDA Inspection 857424 — Kabco Pharmaceuticals, Inc.

Kabco Pharmaceuticals, Inc. — FEI 2434805

The FDA completed an inspection of Kabco Pharmaceuticals, Inc. on November 26, 2013 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 26, 2013
Fiscal Year
2014
Product Type
Food/Cosmetics
Project Area
Foodborne Biological Hazards
Location
Amityville, NY (United States)

Citations

IDCFRDescription
1566521 CFR 111.303Written procedures - tests, examinations; specifications met
1574721 CFR 111.210(g)Packaging description, representative label
1585821 CFR 111.75(a)(1)(i)Component - verify identity, dietary ingredient
1589921 CFR 111.83(b)(1)Reserve sample container-closure contamination,deterioration